Definitive Contract HHSN272201800011C

Ended Awarded Last action

Contract number
HHSN272201800011C
Awardee
Awarding agency
Obligated
$10,299,171

Award facts

Opportunity
  • HHSNIHNIAIDBAA20171 Solicitation number
Contract value 100% obligated
$10,299,171.18 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Minneapolis, MN 55435, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00020 $0
Other Administrative Action P00019 · An NHP efficacy study of BIO 300 for mitigator for deare-induced pneumonitis and pulmonary fibrosis $0
Funding Only Action P00018 · Deobligate funds from line item. -$7
Other Administrative Action P00017 · IPP:an NHP efficacy study of BIO 300 for mitigator for deare-induced pneumonitis and pulmonary fibrosis $0
Other Administrative Action P00016 $0
Other Administrative Action P00015 $0
Other Administrative Action P00014 $0
Exercise an Option P00013 $1,872,652
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 · An NHP efficacy study of BIO 300 for mitigator for deare-induced pneumonitis and pulmonary fibrosis $0
Supplemental Agreement for work within scope P00009 · Supplemental work-sars-COV-2 $2,137,190
Supplemental Agreement for work within scope P00008 $503,859
Exercise an Option P00007 · An NHP efficacy study of BIO 300 for mitigator for deare-induced pneumonitis and pulmonary fibrosis $1,833,338
Other Administrative Action P00006 · To modify article b.2. Estimated cost and article b.3 advanced understandings. $0
Exercise an Option P00005 · To exercise option 1, year 2 for period 04/1/19 - 03/31/20. $1,939,354
Other Administrative Action P00004 · To revise a subcontract with university of maryland, baltimore, to increase the not-to-exceed amount in the base year and option 1, year 2. $0
Change Order P00003 · Provides funds in the amount of $239,683 to conduct NHP PBI study and mouse model study. $239,683
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award An NHP efficacy study of BIO 300 for mitigator for deare-induced pneumonitis and pulmonary fibrosis $1,773,102
Show all 21

About this award

Written by GovTribe AI ·

This is a $10,299,171.18 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Humanetics Corp, a for-profit biopharmaceutical company. The contract is for an NHP (non-human primate) efficacy study of BIO 300, a therapeutic candidate being developed by Humanetics to mitigate radiation-induced pneumonitis and pulmonary fibrosis. This work builds on Humanetics' prior federal grants from agencies like NIH, DoD, and the Army for research and development of radiation mitigation treatments and COVID-19 lung therapies. The contract has a period of performance through September 30, 2025 and does not utilize a set-aside. Humanetics also holds a separate $19.5 million Other Transaction Agreement from the Army to develop an oral formulation of BIO 300.

Quick answers

Who was awarded contract HHSN272201800011C?

HHSN272201800011C was awarded to Humanetics Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 29, 2018.

How much is contract HHSN272201800011C worth?

The government has obligated $10,299,171 on HHSN272201800011C.

Was contract HHSN272201800011C competed?

The extent of competition for HHSN272201800011C was full and open competition. The government received 12 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login